The myelin oligodendrocyte glycoprotein (MOG): A model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis

Journal of Neural Transmission, Supplement

Volumn , Issue 58, 2000, Pages 123-133

  Stefferl, A ^a   Brehm, U ^a   Linington, C ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EPITOPE; GLYCOPROTEIN; PROTEIN MOG; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; CONFERENCE PAPER; DEMYELINATION; DNA POLYMORPHISM; EXPERIMENTAL INFECTION; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

EID: 0033710540     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6284-2_10     Document Type: Conference Paper

References (38)

1. The N-terminal domain of the myelin oligodoendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat
2. Experimental autoimmune encephalomyelitis: The antigen specificity of T-lymphocytes determines the topography of lesions in the central and peripheral nervous system
3. Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG)
4. Differential ultrastructural localization of myelin basic protein, myelin/oligodendrocyte glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats
5. Membrane topology of the myelin/oligodendrocyte glycoprotein
6. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
7. Genetic control of susceptibility to experimental allergic encephalomyelitis in rats
8. Creation of a model for multiple sclerosis in Callithrix jacchus marmosets
9. Identification of autoantibodies associated with myelin damage in multiple sclerosis
10. Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides
11. Analysis Of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55
12. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice
13. Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis
14. Elevated levels of antibody to myelin oligodendrocyte glycoprotein is not specific for patients with multiple sclerosis
15. Reactivity to myelin antigens in multiple sclerosis
16. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions
17. Investigation of myelin/oligodendrocyte glycoprotein membrane topology
18. Mapping of H2-M homolog and MOG genes in the rat MHC
19. Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions
20. The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membranes
21. Multiple sclerosis: T and B cell responses to the extracellular domain of the myelin glycoprotein
22. Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titer to myelin/oligodendrocyte glycoprotein (MOG)
23. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
24. The role of complement in the pathogenesis of experimental allergic encephalomyelitis
25. T cells specific for the myelin oligodendrocyte glycoprotein (MOG) mediate an unusual autoimmune inflammatory response in the central nervous system
26. Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex
27. Physical mapping of human and mouse MOG gene at the distal end of the MHC class Ib region
28. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement
29. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis
30. Myelin oligodendrocyte glycoprotein specific autoantibodies in multiple sclerosis
31. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease
32. Multiple sclerosis: In situ evidence for antibody - And complement-mediated demyelination
33. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology
34. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
35. + positive multiple sclerosis
36. Animal models
37. MHC haplotype-dependent regulation of MOG-induced EAE in rats
38. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls